<table>
<tr>
<th>Change</th>
<th>Details of Change</th>
<th>Level of Evidence</th>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>ENE in HPV-negative cancers: Presence of ENE is designated pN2a for a single ipsilateral node &lt;3 cm and pN3b for all other node(s).</td>
<td>II1</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Classification of ENE: Clinically overt ENE is classified as ENE, and is considered ENE(+) for cN.</td>
<td>III3</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Classification of ENE: Pathologically detected ENE is classified as either ENEmi (â‰¤2mm) or ENEma (&gt; 2mm) for data collection purposes only, but both are considered ENE(+) for definition of pN.</td>
<td>III3</td>
</tr>
</table>

##### ICD-0-3 Topography Codes
<table>
<tr>
<th>Code</th>
<th>Description</th>
</tr>
<tr>
<td>C12.9</td>
<td>Pyriform sinus</td>
</tr>
<tr>
<td>C13.0</td>
<td>Postcricoid region</td>
</tr>
<tr>
<td>C13.1</td>
<td>Hypopharyngeal aspect of aryepiglottic fold</td>
</tr>
<tr>
<td>C13.2</td>
<td>Posterior wall of hypopharynx</td>
</tr>
<tr>
<td>C13.8</td>
<td>Overlapping lesion of hypopharynx</td>
</tr>
<tr>
<td>C13.9</td>
<td>Hypopharynx, NOS</td>
</tr>
<tr>
<td>C01.9</td>
<td>Base of tongue, NOS</td>
</tr>
<tr>
<td>C02.4</td>
<td>Lingual tonsil</td>
</tr>
<tr>
<td>C05.1</td>
<td>Soft palate, NOS</td>
</tr>
<tr>
<td>C05.2</td>
<td>Uvula</td>
</tr>
<tr>
<td>C09.0</td>
<td>Tonsillar fossa</td>
</tr>
<tr>
<td>C09.1</td>
<td>Tonsillar pillar</td>
</tr>
<tr>
<td>C09.8</td>
<td>Overlapping lesion of tonsil</td>
</tr>
<tr>
<td>C09.9</td>
<td>Tonsil, NOS</td>
</tr>
<tr>
<td>C10.0</td>
<td>Vallecula</td>
</tr>
<tr>
<td>C10.2</td>
<td>Lateral wall of oropharynx</td>
</tr>
<tr>
<td>C10.3</td>
<td>Posterior wall of oropharynx</td>
</tr>
<tr>
<td>C10.8</td>
<td>Overlapping lesion of oropharynx</td>
</tr>
<tr>
<td>C10.9</td>
<td>Oropharynx, NOS</td>
</tr>
<tr>
<td>C11.1</td>
<td>Pharyngeal tonsils</td>
</tr>
</table>